A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes
Marie-Andrée Forget(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(BMC Software (United States))
Cited by 55
Related Papers
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Phase 2 study of pembrolizumab in patients with advanced rare cancers
|Journal for ImmunoTherapy of Cancer|2020|130
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
|Cancer Discovery|2018|100